Fundz

Revive Therapeutics raises $91,400 in the second tranche of its private placement. The funds will be used for working capital and trade payables.

PRIVATESep 19, 2025

Amount Raised

$91,400

Round Type

Post-IPO Equity

VaughanBiotechnologyHealth CareTherapeutics

Description

Revive Therapeutics Ltd. announced the closing of the second tranche of its private placement, issuing 4,352,381 units at $0.021 each, resulting in gross proceeds of $91,400. Each unit consists of a common share and a warrant for an additional share at $0.05 for 36 months. The proceeds will support working capital and payment of trade payables

Quick answer

Revive Therapeutics raised $91,400 in a Post-IPO Equity round, dated September 19, 2025. Revive Therapeutics is based in Vaughan, Ontario, Canada.

How much did Revive Therapeutics raise?
Revive Therapeutics raised $91,400 in a Post-IPO Equity round on September 19, 2025.
What does Revive Therapeutics do?
Revive Therapeutics is a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs.
Where is Revive Therapeutics based and how big is it?
Revive Therapeutics is based in Vaughan, Ontario, Canada. Fundz records about 5 employees.
Who are the decision-makers at Revive Therapeutics?
Fundz holds 1 contact at Revive Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Revive Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
  • Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
  • CoRegen raised $14M on October 28, 2025.
  • Hemab Therapeutics raised $157M (Series C) on October 27, 2025.
  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • ENA Respiratory raised $22M (Series B) on October 22, 2025.

Who to call at Revive Therapeutics, and when

A new round usually means Revive Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Revive Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Revive Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Revive Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Revive Therapeutics

Location

Vaughan, Ontario, Canada

About

Revive Therapeutics is a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs. Revive strategically prioritizes its drug development pipeline to leverage FDA regulatory incentives like Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations, positioning for rapid advancement and market entry. Currently, our efforts are concentrated on unlocking the vast potential of Bucillamine for infectious diseases and medical countermeasures, including the pioneering treatment of nerve agent exposure. Furthermore, Revive is vigorously advancing our Psilocybin and molecular hydrogen therapeutic programs, exploring new frontiers in medical science.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Revive Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Revive Therapeutics's next move

See what Strategic adds

Revive Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.